Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages-Reference-Cited by-同舟云学术

Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages

Published:2020-04-12 Issue:3 Volume:66 Page:899-911
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Moctezuma-Velazquez Carlos,Montano-Loza Aldo J.,Meza-Junco Judith,Burak Kelly,Ma Mang,Bain Vincent G.,Kneteman Norman,Sarlieve Phillipe,Owen Richard J.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-020-06245-y.pdf

Reference42 articles.

1. Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev. 2016;25:16–27. https://doi.org/10.1158/1055-9965.EPI-15-0578.

2. Wong MC, Jiang JY, Goggins WB, et al. International incidence and mortality trends of liver cancer: a global profile. Sci Rep. 2017;7:45846. https://doi.org/10.1038/srep45846.

3. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018. https://doi.org/10.1016/j.jhep.2018.03.019.

4. Vilgrain V, Pereira H, Assenat E, et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18:1624–1636. https://doi.org/10.1016/S1470-2045(17)30683-6.

5. Chow PKH, Gandhi M, Tan SB, Khin MW, Khasbazar A, Ong J et al. SIRveNIB: selective internal radiation therapy versus Sorafenib in Asia-Pacific patients with hepatocellular carcinoma. J Clin Oncol. 2018:JCO2017760892. https://doi.org/10.1200/jco.2017.76.0892.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy;Annals of Hepatology;2025-01

2. Prognostic role of albumin-bilirubin (ALBI) score and Child-Pugh classification in patients with advanced hepatocellular carcinoma under systemic treatment;ecancermedicalscience;2024-08-27

3. Enhanced therapeutic outcomes with atezolizumab-bevacizumab and SIRT combination compared to SIRT alone in unresectable HCC: A promising approach for improved survival;Clinics and Research in Hepatology and Gastroenterology;2024-02

4. Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization;Pharmaceuticals;2023-12-01

5. Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial;Hepatology Communications;2023-05-23